Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR to Lead Resolutions at June AMA House of Delegates Meeting

From the College  |  May 23, 2023

Additionally, there are concerns about the proposed changes’ impacts on publishers’ ability to maintain meaningful peer review. Diligent peer review, management and public disclosures of conflicts, and data and figure integrity checks are vital parts of the process. Such threats as plagiarism, “paper mills” and fraudulent data are increasingly present and require steady attention. Maintaining this trusted role in society, at a time when disinformation is rampant, requires a significant investment. However, the absence of significant revenue from subscriptions could diminish the incentive for publishers to maintain meaningful peer review.  This along with other concerns has the potential to cause significant harm to the viability of the U.S. biomedical research enterprise.

Joining the ACR in raising concerns and calling for AMA involvement through this resolution include: American Academy of Allergy, Asthma and Immunology; American Academy of Neurology; American College of Physicians; American Society of Anesthesiologists; American Society of Hematology; American Society for Radiation Oncology; American Thoracic Society; American Urological Association; Association for Clinical Oncology; and Endocrine Society.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Resolutions are introduced and considered by the ACR based on its positions and policies and the work of ACR committees and the Board of Directors. The ACR’s delegation to the AMA House of Delegates consists of Gary Bryant, MD (Delegate and Delegation Chair), Eileen Moynihan, MD (Delegate), Cristina Arriens, MD (Alternate Delegate), Colin Edgerton, MD (Alternate Delegate), Luke Barre, MD (Young Physician Section representative), Christina Downey, MD (Young Physician Section representative), and Rami Diab, MD (Resident and Fellows Section representative).

The ACR encourages rheumatologists to join or renew membership in the AMA so that this work may continue. Input on the AMA delegation’s work on behalf of the rheumatology community—along with questions or suggestions for this House of Delegates meeting—can be directed to [email protected]. The ACR offers individualized assistance to ACR and ARP members. If you are experiencing specific issues with payers or have other insurance, coding, billing or practice concerns, write to [email protected].

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:AMA House of Delegates (HOD)In-office treatmentNational Institutes of Healthresearch publishing

Related Articles

    The ACR’s Representation in American Medical Association Critical as Review Looms

    March 17, 2017

    There is a saying that if the American Medical Association (AMA) did not exist, we would have to invent it. That is just what Dr. Nathan S. Davis did back in 1845 when he called for a national medical convention and laid the foundation for the establishment of the AMA in 1847. This new group would…

    Rheumatology Priorities Advanced at Busy AMA House of Delegates Meeting

    June 16, 2023

    Two ACR-led resolutions on in-office specialty drug dispensing and the proposed NIH Public Access Plan passed the House of Delegates and will become AMA policy.

    Pointers for Rheumatologists Considering AMA Membership

    February 3, 2012

    Join the AMA. Don’t join because you agree with everything the AMA does. Join so we, as rheumatologists, will continue to have a voice and make a difference.

    Why Keep a Seat at the AMA Table?

    January 18, 2017

    As 2017 unfolds—a year when MACRA begins, lawmakers take steps to dismantle the health reform efforts of the past eight years, and political uncertainty is the rule—it is imperative that the ACR leverage its advocacy agenda by maintaining its seat at the American Medical Association’s (AMA’s) House of Delegates (HOD), says Gary Bryant, MD, FACP…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences